Home Evommune

Evommune

In operation
Post-IPO Round
Biological New Drug Developer

Basic Information

Evommune's focus is on discovering and developing unique therapies to help patients with chronic inflammatory diseases. We are evaluating multiple known and novel targets addressing adaptive and innate immunity. By utilizing a unique screening platform, we identify differentiated molecules that have a higher probability of being effective in treating patients. Our technology, combined with a team that has an extensive track record of successfully developing new drugs, will help accelerate the R&D process so we can serve patients with inflammatory diseases more quickly.
Evommune, Inc.
California,United States of America
less than 15 people
January 01, 2020
--